As a consequence of the unusual breakpoint in the ABL1 gene, the RCSD1/ABL1 protein retains only a part of the ABL SH2 domain, which would predict association of the RCSD1/ABL1 fusion with ALL rather than CML [10]. The gene discussed is RCSD1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.